News > Johnson & Johnson’s single-dose vaccine gets emergency-use approval in India

Johnson & Johnson’s single-dose vaccine gets emergency-use approval in India

Scroll | 07/08/2021 03:11 PM | Click to read full article

Pharmaceutical company Johnson & Johnson’s single-dose Covid-19 vaccine has received emergency-use authorisation in India, Union health minister Mansukh Mandaviya announced on Saturday.

“Now India has 5 EUA vaccines,” the minister added. “This will further boost our nation’s collective fight against Covid-19.” In phase three clinical trials, the single-shot vaccine showed 85% efficacy in preventing severe disease, Johnson & Johnson said.